The U.S. set negotiated drug prices for 2027 under the Inflation Reduction Act, cutting costs for Medicare drugs.

The U.S. has unveiled 2027 negotiated drug prices under the Inflation Reduction Act, delivering major cost cuts for Medicare beneficiaries. Key medications, including top-sellers, saw substantial price reductions following government-pharma negotiations, aiming to improve prescription affordability nationwide.